---All---
  • ---All---
  • Accession
  • Catalog #

HDAC2 Antibody (C-term)Purified Rabbit Polyclonal Antibody (Pab)

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
AP1102b 0.1 mg 400 ul In Stock $ 255.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

HDAC2 Antibody (C-term) - Product info

ApplicationWB, IF, IHC
  • Applications Legend:
  • W=Western Blotting
  • IP=Immunoprecipitation
  • IHC-P=Immunohistochemistry (Paraffin)
  • IF-IC=Immunofluorescence (Immunocytochemistry)
  • F=Flow Cytometry
Primary AccessionQ92769
ReactivityHuman
Concentration0.25 mg/ml
IsotypeRabbit Ig
Calculated MW55364 Da

HDAC2 Antibody (C-term) - Additional info

Gene ID 3066
Other Names
HDAC2; Histone deacetylase 2
Target/Specificity
This HDAC2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide selected from the C-terminal region of human HDAC2.
Dilution
WB~~1:100~500
IF~~1:10~50
IHC~~1:10~50
Format
Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS.
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Precautions
HDAC2 Antibody (C-term) is for research use only and not for use in diagnostic or therapeutic procedures.

HDAC2 Antibody (C-term) - Protein Information

Name HDAC2
Function
Responsible for the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4) Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events. Histone deacetylases act via the formation of large multiprotein complexes. Forms transcriptional repressor complexes by associating with MAD, SIN3, YY1 and N-COR. Interacts in the late S-phase of DNA-replication with DNMT1 in the other transcriptional repressor complex composed of DNMT1, DMAP1, PCNA, CAF1. Deacetylates TSHZ3 and regulates its transcriptional repressor activity. Component of a RCOR/GFI/KDM1A/HDAC complex that suppresses, via histone deacetylase (HDAC) recruitment, a number of genes implicated in multilineage blood cell development
Cellular Location
Nucleus.
Tissue Location
Widely expressed; lower levels in brain and lung

HDAC2 Antibody (C-term) - Related products

AP1102b: HDAC2 Antibody (C-term)

AP9762c: HDAC2 Antibody (Center)

RI12420: HDAC2 predesign siRNA

BP1102b: HDAC2 Antibody (C-term) Blocking Peptide

BP9762c: HDAC2 Antibody (Center) Blocking Peptide

AJ1347a: Histone Deacetylase 2 Antibody (C-term)

AE1014a: HDAC2 Antibody (S394)

AE1014b: Phospho-HDAC2-S394 Antibody

HDAC2 Antibody (C-term) - Application data

  • Western blot analysis of HDAC2 (arrow) using rabbit polyclonal HDAC2 Antibody (C-term) (Cat.#AP1102b).293 cell lysates (2 ug/lane) either nontransfected (Lane 1) or transiently transfected with the HDAC2 gene (Lane 2) (Origene Technologies).

  • Western blot analysis of anti-HDAC2 Antibody (C-term) (Cat.#AP1102b) in 293 cell line lysates (35ug/lane). HDAC2(arrow) was detected using the purified Pab.

  • Western blot analysis of anti-HDAC2 Antibody (C-term) (Cat.#AP1102b) in mouse spleen tissue lysates (35ug/lane). HDAC2(arrow) was detected using the purified Pab.

  • Confocal immunofluorescent analysis of HDAC2 Antibody (C-term)(Cat#AP1102b) with 293 cell followed by Alexa Fluor 488-conjugated goat anti-rabbit lgG (green).Actin filaments have been labeled with Alexa Fluor 555 phalloidin (red).

  • HDAC2 Antibody (C-term) (Cat. #AP1102b)immunohistochemistry analysis in formalin fixed and paraffin embedded human breast carcinoma followed by peroxidase conjugation of the secondary antibody and DAB staining.This data demonstrates the use of HDAC2 Antibody (C-term) for immunohistochemistry. Clinical relevance has not been evaluated.

  • Fluorescent confocal image of Hela cell stained with HDAC2 Antibody (C-term)(Cat#AP1102b).Hela cells were fixed with 4% PFA (20 min), permeabilized with Triton X-100 (0.1%, 10 min), then incubated with HDAC2 primary antibody (1:25, 1 h at 37℃). For secondary antibody, Alexa Fluor® 488 conjugated donkey anti-rabbit antibody (green) was used (1:400, 50 min at 37℃).Cytoplasmic actin was counterstained with Alexa Fluor® 555 (red) conjugated Phalloidin (7units/ml, 1 h at 37℃). Nuclei were counterstained with DAPI (blue) (10 µg/ml, 10 min). hHDAC2 immunoreactivity is localized to Nucleus significantly.

HDAC2 Antibody (C-term) - Research Areas

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

Histone deacetylase 2 (HDAC2), or transcriptional regulator homolog RPD3 L1, is highly homologous to the yeast transcription factor RPD3 (reduced potassium dependency 3) gene. As in yeast, human HDA2 is likely to be involved in regulating chromatin structure during transcription. It has been implicated to associate with YY1, a mammalian zinc-finger transcription factor, which negatively regulates transcription by tethering RPD3 to DNA as a cofactor. This process is highly conserved from yeast to human.

REFERENCES

Choi, Y.B., et al., J. Biol. Chem. 279(49):50930-50941 (2004). Zhu, P., et al., Cancer Cell 5(5):455-463 (2004). Longworth, M.S., et al., J. Virol. 78(7):3533-3541 (2004). Lu, Y., et al., J. Biol. Chem. 278(48):47792-47802 (2003). Verdin, E., et al., Trends Genet. 19(5):286-293 (2003).